This is the first approved monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), an epithelial cytokine released by the airway epithelium that acts as early mediator at the top of the allergic inflammatory cascade in asthma [72,73,74]. The gene discussed is TSLP; the disease is asthma.